|
Click here to view online. Add this email to your safelist. |
|||||||||||
|
|
|||||||||||
|
AstraZeneca aims to transform the oncology treatment landscape with diverse early pipeline and novel combinations at AACR |
|||||||||||
|
|
|||||||||||
|
28 March 2022
AstraZeneca will present new data underscoring the breadth of the Company’s early oncology portfolio at the American Association for Cancer Research (AACR) Annual Meeting in New Orleans, 8 to 13 April 2022. |
|||||||||||
|